Synvolux is an independent company that manufactures products for highly efficient, non-viral delivery of macromolecules, such as DNA, (si)RNA, and protein/peptides. Synvolux’ proprietary delivery technology (SAINT™) is based on fully synthetic cationic lipid structures with proven safety and broad applicability both in vitro and in vivo. SAINT™ products are marketed and used worldwide through direct sales and under various brand names through OEM distributors. In addition, the company is partnering and developing its delivery platform for therapeutic applications in the field of immunotherapy and for novel vaccines against pathogens and cancer to provide life-changing solutions to patients.